Menu Close

DaVita Inc. (NYSE:DVA) Shares Sold by California Public Employees Retirement System

view original post

California Public Employees Retirement System cut its holdings in shares of DaVita Inc. (NYSE:DVAGet Rating) by 7.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 134,357 shares of the company’s stock after selling 10,790 shares during the period. California Public Employees Retirement System owned 0.14% of DaVita worth $15,197,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of DVA. Johnson Financial Group Inc. purchased a new position in DaVita in the 4th quarter valued at $27,000. CWM LLC grew its position in DaVita by 154.1% in the 1st quarter. CWM LLC now owns 432 shares of the company’s stock valued at $49,000 after buying an additional 262 shares during the last quarter. FourThought Financial LLC grew its position in DaVita by 49.6% in the 1st quarter. FourThought Financial LLC now owns 510 shares of the company’s stock valued at $56,000 after buying an additional 169 shares during the last quarter. Cullen Frost Bankers Inc. purchased a new stake in shares of DaVita during the 4th quarter worth $74,000. Finally, Quent Capital LLC purchased a new stake in shares of DaVita during the 4th quarter worth $118,000. 87.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at DaVita

In other news, COO Michael David Staffieri purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, June 23rd. The shares were acquired at an average cost of $77.70 per share, with a total value of $1,554,000.00. Following the transaction, the chief operating officer now owns 61,190 shares in the company, valued at approximately $4,754,463. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, Director Barbara J. Desoer sold 2,320 shares of the firm’s stock in a transaction dated Friday, June 3rd. The stock was sold at an average price of $97.42, for a total transaction of $226,014.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Michael David Staffieri bought 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 23rd. The shares were purchased at an average cost of $77.70 per share, with a total value of $1,554,000.00. Following the purchase, the chief operating officer now directly owns 61,190 shares of the company’s stock, valued at $4,754,463. The disclosure for this purchase can be found here. 1.00% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

DVA has been the subject of several research reports. Barclays cut their price target on DaVita from $128.00 to $103.00 and set an “equal weight” rating for the company in a research note on Thursday. StockNews.com cut DaVita from a “strong-buy” rating to a “buy” rating in a report on Thursday, May 5th. Deutsche Bank Aktiengesellschaft decreased their target price on DaVita from $150.00 to $97.00 and set a “buy” rating for the company in a report on Tuesday. Truist Financial decreased their target price on DaVita from $110.00 to $90.00 and set a “hold” rating for the company in a report on Wednesday, June 22nd. Finally, Bank of America decreased their target price on DaVita from $110.00 to $90.00 and set an “underperform” rating for the company in a report on Tuesday, June 21st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $106.00.

DaVita Stock Up 0.6 %

NYSE DVA opened at $85.31 on Friday. The stock has a market cap of $8.07 billion, a PE ratio of 10.58, a P/E/G ratio of 1.06 and a beta of 1.16. DaVita Inc. has a fifty-two week low of $74.97 and a fifty-two week high of $134.47. The business has a 50 day moving average price of $86.75 and a two-hundred day moving average price of $102.40. The company has a quick ratio of 1.25, a current ratio of 1.41 and a debt-to-equity ratio of 11.69.

DaVita (NYSE:DVAGet Rating) last released its quarterly earnings results on Monday, August 1st. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.09 by $0.21. The firm had revenue of $2.93 billion during the quarter, compared to analysts’ expectations of $2.93 billion. DaVita had a return on equity of 84.69% and a net margin of 7.17%. DaVita’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.64 EPS. As a group, sell-side analysts predict that DaVita Inc. will post 7.72 EPS for the current fiscal year.

DaVita Profile

(Get Rating)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

See Also

Receive News & Ratings for DaVita Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for DaVita and related companies with MarketBeat.com’s FREE daily email newsletter.